Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dubey

Showing results (101-110 of 202) with videos related to

Pageof 21
Sort By:
Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Mabs|October 23, 2015
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell culturesKara S Cox, Aimin Tang, Zhifeng Chen, et al.
Cellular Immunology|April 13, 2010
Synthesis and immunological activities of novel agonists of toll-like receptor 9Mary Struthers, Andrew J Bett, Thomas Wisniewski, et al.
AIDS Research and Human Retroviruses|December 7, 2006
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjectsTimothy W Tobery, Sheri A Dubey, Kiersten Anderson, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Nature Medicine|July 22, 2009
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansKara L O'Brien, Jinyan Liu, Sharon L King, et al.
Vaccine|October 13, 2010
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humansAndrew J Bett, Sheri A Dubey, Devan V Mehrotra, et al.
The Journal of Infectious Diseases|November 26, 2009
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimensDavid M Asmuth, Elizabeth L Brown, Mark J DiNubile, et al.
AIDS Research and Human Retroviruses|December 26, 2008
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsClayton D Harro, Michael N Robertson, Michelle A Lally, et al.
Science Translational Medicine|November 1, 2016
A replication-defective human cytomegalovirus vaccine for prevention of congenital infectionDai Wang, Daniel C Freed, Xi He, et al.
Pageof 21

Showing results (101-110 of 202) with videos related to

Sort By:
Pageof 21
Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Mabs|October 23, 2015
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell culturesKara S Cox, Aimin Tang, Zhifeng Chen, et al.
Cellular Immunology|April 13, 2010
Synthesis and immunological activities of novel agonists of toll-like receptor 9Mary Struthers, Andrew J Bett, Thomas Wisniewski, et al.
AIDS Research and Human Retroviruses|December 7, 2006
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjectsTimothy W Tobery, Sheri A Dubey, Kiersten Anderson, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Nature Medicine|July 22, 2009
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansKara L O'Brien, Jinyan Liu, Sharon L King, et al.
Vaccine|October 13, 2010
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humansAndrew J Bett, Sheri A Dubey, Devan V Mehrotra, et al.
The Journal of Infectious Diseases|November 26, 2009
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimensDavid M Asmuth, Elizabeth L Brown, Mark J DiNubile, et al.
AIDS Research and Human Retroviruses|December 26, 2008
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsClayton D Harro, Michael N Robertson, Michelle A Lally, et al.
Science Translational Medicine|November 1, 2016
A replication-defective human cytomegalovirus vaccine for prevention of congenital infectionDai Wang, Daniel C Freed, Xi He, et al.
Pageof 21